Blog

Cilostazol Fails to Best Aspirin for Post-Stroke Secondary Prevention
MedPage Today
HOUSTON — For ischemic stroke patients with evidence of leaky blood vessels in the brain, the phosphodiesterase 3 (PDE3) inhibitor cilostazol was non-inferior to aspirin for reducing a composite of cardiovascular events, but it didn’t prove superior, …